In spinal schwannoma, one study reported a mutation in the large tumor suppressor kinase 1 gene (LATS1), a downstream mediator of NF2, but the clinical relevance of these alterations remains unknown in spinal meningiomas (28). This evidence concerns the gene LATS1 and spinal meningioma.